According to a market report by Lucintel, the future of the global drug-eluting stent market looks promising with opportunities in the coronary artery disease and peripheral artery disease markets. The global drug-eluting stent market is expected to reach an estimated $13 billion by 2030 with a CAGR of 6.3% from 2024 to 2030. The major drivers for this market are increasing global elderly population and rising incidence of cardiovascular disorders.
A more than 150–page report is developed to understand Trends,
opportunity and forecast in drug-eluting stent market to 2030 by coating type
(polymer-based coating and polymer-free coating), application (coronary artery
disease and peripheral artery disease), and region (North America, Europe, Asia
Pacific, and the Rest of the World).
In this market, polymer-based coating and polymer-free coating are the
major segments of drug-eluting stent market by coating type. Lucintel forecasts
that polymer-based coatings will remain the larger segment over the forecast
period due to its proven effectiveness and adaptability.
Within this market, coronary artery disease will remain the larger
segment due to increasing global incidence of coronary artery disease.
Download sample by clicking on drug-eluting
stent market
North America will remain the largest region over the forecast period due
to presence of well-developed healthcare infrastructure and widespread adoption
of advanced medical technologies in the region.
Boston Scientific, Medtronic, Abbott Laboratories, Biosensors, Biotronik,
Lepu Medical Technology, Terumo Medical, Cook Medical, Shandong JW Medical
Systems, and B.Braun are the major suppliers in the drug-eluting stent market.
This unique research report will enable you to make confident business
decisions in this globally competitive marketplace. For a detailed table of
contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com
About Lucintel
At Lucintel, we offer solutions for you growth
through game
changer ideas and robust market & unmet
needs analysis. We are based in Dallas, TX and have
been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in
several publications like the Wall Street Journal, ZACKS, and the Financial
Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1 972.636.5056
Explore Our Latest
Publications
Wind
Turbine Gear Lubricant Market in Canada
Zeolite
Powder Market in Canada
No comments:
Post a Comment